JAC Advance Access originally published online on February 9, 2007
Journal of Antimicrobial Chemotherapy 2007 59(3):573; doi:10.1093/jac/dkl520
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Correspondence |
Comment on: Guidelines for the prevention of endocarditis: report of the Working Party of the British Society for Antimicrobial Chemotherapy
1 Microbiology Department Unit, Birmingham Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, UK 2 Paediatric Intensive Care Unit, Birmingham Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, UK
* Corresponding author. Tel: +44-191-3339816; Fax: +44-191-3339811; E-mail: clive.graham@bch.nhs.uk
Keywords: Staphylococcus aureus , prophylaxis , endocarditis
| The first 10% of the full text of this article appears below. |
Dear Sir,
We would like to comment on the recommended prophylactic regimen for nasal packing and nasal intubation contained within the Working Party Guidelines for the prevention of endocarditis. In these guidelines, flucloxacillin or clindamycin is recommended for these procedures when they are performed in patients at
Transparency declarations